CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
10 research outputs found
Prophylactic use of anti-emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open-label, parallel-group, single-dose study in healthy subjects
Author
Alaven Pharmaceutical LLC
Amylin Pharmaceuticals Inc
+10 more
Buse
DeFronzo
Fineman
GlaxoSmithKline
Kendall
Klonoff
Moretto
Peters
Siminerio
Zinman
Publication venue
Blackwell Publishing Ltd
Publication date
Field of study
Get PDF
Crossref
PubMed Central
Comparison of treatment patterns and economic outcomes in metastatic breast cancer patients initiated on trastuzumab versus lapatinib: a retrospective analysis
Author
A Borg
A Elixhauser
+19 more
AJ Montero
CT Guy
DJ Slamon
DJ Slamon
DJ Slamon
G Gullo
Genentech Inc.
Genentech Inc.
Genentech Inc.
GlaxoSmithKline LLC
H Quan
M Mayer
M Vera-Llonch
National Comprehensive Cancer Network
PharMetrics
PJ Medina
R Siegel
Susan G Komen Foundation
V Kumar
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Get PDF
Crossref
The Duty to Disclose Adverse Clinical Trial Results
Author
Beauchamp T.
Bouchie A.
+30 more
Clarke S.
Cranston M.
DeAngelis C. D.
Eli Lilly and Company
Faden R. R.
Gert B.
Gewirth A.
GlaxoSmithKline
Griffin J.
Hoyert D. L.
Institute of Medicine of the National Academies
Jobson Medical Information LLC
Lichtenberg F. R.
Lichtenberg F. R.
Lichtenberg F. R.
Mark Sheehan
Mathews A.
Merck &
Merck&
Raz J.
S. Matthew Liao
Schneider C. K.
Sim I.
Steve Clarke
Thomson L.
United States Department of Health and Human Services Centers for Disease Control and Prevention, National Center for Health Statistics
United States Food and Drug Administration Center for Drug Evaluation and Research
Walters L.
Wear S.
World Health Organization
Publication venue
'Informa UK Limited'
Publication date
Field of study
Full text link
Crossref
Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease
Author
Ahlskog
Boehringer Ingelheim International GmbH
+16 more
Campbell
Chapuis
Dewey
GlaxoSmithKline
GlaxoSmithKline
Hauser
Hauser
Lees
LeWitt
Lieberman
Merims
Mouradian
Olanow
Stacy
Stocchi
US WorldMeds LLC
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques
Author
Bower WA
Cangene Corporation
+7 more
Clinical and Laboratory Standards Institute
Elusys Therapeutics Inc
Emergent BioDefense Operations Lansing LLC
FDA
GlaxoSmithKline
Grossman TH
Wright JG
Publication venue
'American Society for Microbiology'
Publication date
Field of study
No full text
Crossref
Evaluation of Hepatic Impairment Dosing Recommendations in FDA-Approved Product Labels
Author
Amgen Inc
Celgene Corporation
+20 more
Delcò
Eisai Inc
Forest Pharmaceuticals Inc
GlaxoSmithKline
Jellinek
Lundbeck Inc
Novartis Pharma Stein AG
Novartis Pharmaceuticals Corporation
Otsuka Pharmaceutical Co. Ltd
Pfizer Inc
Pfizer Inc
Sanofi-Aventis
Sanofi-Aventis
Sunovion Pharmaceuticals Inc
Verbeeck
Vertex Pharmaceuticals Incorporated
ViiV Healthcare
Warner Chilcott (US) LLC
Xu
Younossi
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Severe Asthma in Primary Care: Identification and Management
Author
Amelink
AstraZeneca
+47 more
AstraZeneca AB
Bahadori
Blain
Bleecker
Bradley E. Chipps
Canonica
Carr
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
Chipps
Chipps
Chung
Cordier
Demarche
Dinakar
Fajt
FitzGerald
Genentech Inc.
GlaxoSmithKline LLC
Global Initiative for Asthma
Jennifer L. Trevor
Johnson
Juniper
Kolbeck
Laviolette
Manson
McGeachie
Murphy
Nair
Nathan
National Heart Lung and Blood Institute
Nunes
O'Byrne
Optum
Price
Qoltech
Rance
Robinson
Schierhorn
Skloot
Sweeney
Tai
Teva Respiratory LLC
Varricchi
Wenzel
Wenzel
Wilhelm
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus: Recent Developments and Emerging Agents
Author
Ahren
Ahren
+50 more
Barrington
Bolli
Buse
Buse
Buse
Centers for Disease Control and Prevention
Degn
Drucker
Dungan
Fonseca
Giorgino
GlaxoSmithKline LLC
Gotfredsen
Hansen
Harrison
Henry
Inzucchi
Jendle
Kapitza
Kielgast
Kim
Kolterman
Kuhadiya
Leiter
Mathieu
Meier
Moreno
Nauck
Nauck
Petersen
Pinget
Pratley
Pratley
Reinhardt
Reusch
Riddle
Riddle
Rosenstock
Rosenstock
Rosenstock
Seino
Stewart
Tang-Christensen
Turner
Turton
Umpierrez
Unger
Varanasi
Wadden
Wysham
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Investigational drugs to treat methicillin-resistant Staphylococcus aureus
Author
Anthony J. Yeh
Aridis Pharmaceuticals I
+38 more
Bagnoli F
Caballero A
CDC
Cellceutix C
Chambers HF
ContraFect
CrystalGenomics I
Cuong Vuong
Dantes R
Debiopharm International SA
Delfani S
Ebert T
Fattom AI
GangaGen I
GlaxoSmithKline
Gordon YC Cheung
Kyorin Pharmaceutical Co. L. KRP-AM1977Y
Lee JC
LegoChem Biosciences I
LegoChem Biosciences I
MedImmune LLC
MedImmune LLC
Melinta Therapeutics I
Michael Otto
MicuRx
Moreillon P
National Institute of Allergy and Infectious Diseases
Pfizer
Pfizer
Pfizer
Pfizer
Pfizer
Sanofi
WHO
Wockhardt
Wockhardt
Wockhardt
Wockhardt Clinartis
Publication venue
'Informa Healthcare'
Publication date
Field of study
No full text
Crossref
Disaster Preparedness: Biological Threats and Treatment Options
Author
Abbink
Adalja
+91 more
American Pharmacists Association
American Society of Health-System Pharmacists
Anantpadma
Andrei
Arnon
Arnon
Athamna
Atkinson
Bai
Bishop
Booth
Borio
Bower
Bradley
Brasil
Cangene Corp
Cangene Corp
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention (CDC)
Centers for Disease Control and Prevention (CDC)
Cohen
D'Ortenzio
Dellinger
Dennis
Dowd
Elusys
Emergent BioDefense Operations Lansing LLC
Fagan
Frieden
Geisbert
GlaxoSmithKline
Grubaugh
Hanczaruk
Henao-Restrepo
Henao-Restrepo
Henderson
Hendricks
Hill
Hodowanec
Hou
Inglesby
Jernigan
Jorgenson
Katharios-Lanwermeyer
Khabbaz
Kool
Kretzschmar
Kwit
Larocca
Martin
Mead
Meselson
Meyerhoff
Migone
Migone
Miller
Mlakar
Morens
Morens
Mucker
Mwengee
Mytle
Nalca
Nicastri
Olson
Penn
Petersen
Petersen
Reardon
Rhodes
Runfola
Singer
Spengler
Stanley
Stevens
Taubenberger
Tebas
The PREVAIL II Writing Group for the Multi-National PREVAIL II Study Team
Treanor
Trost
Tunkel
Turmel
USAMIIRD
Wheelis
Woodard
World Health Organization
Wright
Yamamoto
Zhu
Zhu
Zimmer
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref